Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-17-013430
Filing Date
2017-12-19
Accepted
2017-12-19 17:20:25
Documents
3

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT f424b5121917_immucellcorp.htm 424B5 326491
2 GRAPHIC image_001.jpg GRAPHIC 4749
3 GRAPHIC logo.jpg GRAPHIC 6850
  Complete submission text file 0001213900-17-013430.txt   343673
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-207635 | Film No.: 171264889
SIC: 2835 In Vitro & In Vivo Diagnostic Substances